Meimei's, a Chinese-influenced French bistro, is slated for 143 Orchard Street on the Lower East Side with a menu that mixes French technique and Chinese ingredients.

A 43-year-old man was robbed at knifepoint at Fifth Avenue 6th Street; NYPD Crime Stoppers has posted a reward for tips. Police say the suspect fled on foot.

Howden signed a 10-year lease for the full 53rd floor at Durst’s One Five One in Times Square, taking roughly 31,519 square feet. The move highlights demand for upgraded Midtown office product.

Alchemy paid about $57M for a five‑story garage at 56–60 North Moore in Tribeca and plans to add floors and convert it into ultra‑luxury condominiums.

A corner property at 120 Court Street sold for $30M; filings show a 14‑story, 75‑unit building and Walgreens is set to vacate this summer.

Bill Clinton joined a groundbreaking in Crown Heights for an $18M Anchor House expansion that will add a new men's residential building and about 70 beds.

The NYPD bomb squad investigated a grenade-like object found inside a Sheepshead Bay home; technicians later declared it inert and no one was hurt. Neighbors say it may have been an old military relic.

Ten Carnegie Mellon alumni earned a record 15 Tony nominations across acting, design and producing, with nominees ranging from Will Harrison to veteran producers.

Related CEO Jeff Blau told the TRD Forum New York is still the center of real estate even as the firm pushes into data centers and faces protests over Hudson Yards financing.

A lender has sued to foreclose on the West Village property that houses Casa La Femme at 140 Charles St, raising questions about the restaurant and nearby apartments. Court dockets will determine the next steps.

MLS opened a 126,000-square-foot global headquarters at Penn 2 in Midtown, consolidating match-day operations, studios and event space ahead of the 2026 World Cup.

One year after a $160M makeover, the Davis Center at Harlem Meer has drawn more than 170,000 visitors and reshaped Central Park’s north end.

Memorial Sloan Kettering posted a $47.9M operating loss for 2025 after a costly Epic EHR rollout and rising drug and supply costs. Leadership says volumes rebounded but margins are squeezed.